Immune therapy including dendritic cell based therapy in chronic hepatitis B virus infection

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 18

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

406

HTML

2684

Figures (1-2)

202

Tables (1-2)

202

Sum=3494

May 14, 2006 (publication date) through Nov 19, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastroenterol. May 14, 2006; 12(18): 2876-2883
Published online May 14, 2006. doi: 10.3748/wjg.v12.i18.2876

Table 1 Role of immune responses in chronic HBV carrier

	HBV carriers	Possible causes
A: Acquisition of chronic State	A: Neonates of HBV- carrier mothers	Inability to induce HBV- specific immunity
A: Acquisition of chronic State	B: Immune suppressed Individuals
B: Induction and Progression of Hepatitis	Chronic hepatitis B	Accumulation of non-specific lymphocytes
C: Recovery from chronic HBV infection	A: Natural recovery	A: Strong and multispecific
	B: Acute hepatitis	HBV-related immune
	C: By antiviral drugs	responses
		B: Antiviral therapy effective in immune modulatory phase

Citation: Akbar SMF, Horiike N, Onji M. Immune therapy including dendritic cell based therapy in chronic hepatitis B virus infection. World J Gastroenterol 2006; 12(18): 2876-2883
URL: https://www.wjgnet.com/1007-9327/full/v12/i18/2876.htm
DOI: https://dx.doi.org/10.3748/wjg.v12.i18.2876